NLRP3 inflammasome induces CD4+ T cell loss in chronically HIV-1–infected patients

Chao Zhang,Jin-Wen Song,Hui-Huang Huang,Xing Fan,Lei Huang,Jian-Ning Deng,Bo Tu,Kun Wang,Jing Li,Ming-Ju Zhou,Cui-Xian Yang,Qi-Wen Zhao,Tao Yang,Li-Feng Wang,Ji-Yuan Zhang,Ruo-Nan Xu,Yan-Mei Jiao,Ming Shi,Feng Shao,Rafick-Pierre Sékaly,Fu-Sheng Wang
DOI: https://doi.org/10.1172/jci138861
IF: 19.456
2021-03-15
Journal of Clinical Investigation
Abstract:Chronic HIV-1 infection is generally characterized by progressive CD4<sup>+</sup> T cell depletion due to direct and bystander death that is closely associated with persistent HIV-1 replication and an inflammatory environment in vivo. The mechanisms underlying the loss of CD4<sup>+</sup> T cells in patients with chronic HIV-1 infection are incompletely understood. In this study, we simultaneously monitored caspase-1 and caspase-3 activation in circulating CD4<sup>+</sup> T cells, which revealed that pyroptotic and apoptotic CD4<sup>+</sup> T cells are distinct cell populations with different phenotypic characteristics. Levels of pyroptosis and apoptosis in CD4<sup>+</sup> T cells were significantly elevated during chronic HIV-1 infection, and decreased following effective antiretroviral therapy. Notably, the occurrence of pyroptosis was further confirmed by elevated gasdermin D activation in lymph nodes of HIV-1–infected individuals. Mechanistically, caspase-1 activation closely correlated with the inflammatory marker expression and was shown to occur through NLRP3 inflammasome activation driven by virus-dependent and/or -independent ROS production, while caspase-3 activation in CD4<sup>+</sup> T cells was more closely related to T cell activation status. Hence, our findings show that NLRP3-dependent pyroptosis plays an essential role in CD4<sup>+</sup> T cell loss in HIV-1–infected patients and implicate pyroptosis signaling as a target for anti–HIV-1 treatment.
medicine, research & experimental
What problem does this paper attempt to address?